富国银行首次覆盖Praxis Precision Medicines 给予持股观望评级 目标价282美元

美股速递
Feb 02

富国银行发布最新研报,宣布对精准医疗公司Praxis Precision Medicines, Inc. (PRAX) 启动覆盖研究。该机构给予该公司"持股观望"评级,同时设定目标股价为每股282美元。

此次覆盖标志着华尔街对这家生物技术企业的关注度提升。分析师在报告中指出,虽然公司在新药研发领域展现潜力,但当前估值已基本反映其成长前景,因此建议投资者保持谨慎乐观态度。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10